ASHP statement on the pharmacy and therapeutics committee.

Daniel T. Abazia, P. Anderson, L. Azzopardi, K. R. Baker, James L. Besier, J. Bootman, D. Bowyer, M. Brady, M. Chrymko, J. Cranston, S. Dzierba, M. Gaunt, P. C. Hagan, R. W. Hammond, E. Hola, P. Kienle, Katharine Kiser, T. L. Kurt, T. R. Lanese, Rosario J. Lazzaro, M. E. Liter, P. Malone, C. Morello, Richard O'Brocta, F. Odedina, J. Ponto, C. W. Quap, M. Rouse, M. Schlaifer, Shelley H. Schliesser, M. Shepherd, Jonalan Smith, A. Vaida, W. Wade, T. Woller, J. Woon
{"title":"ASHP statement on the pharmacy and therapeutics committee.","authors":"Daniel T. Abazia, P. Anderson, L. Azzopardi, K. R. Baker, James L. Besier, J. Bootman, D. Bowyer, M. Brady, M. Chrymko, J. Cranston, S. Dzierba, M. Gaunt, P. C. Hagan, R. W. Hammond, E. Hola, P. Kienle, Katharine Kiser, T. L. Kurt, T. R. Lanese, Rosario J. Lazzaro, M. E. Liter, P. Malone, C. Morello, Richard O'Brocta, F. Odedina, J. Ponto, C. W. Quap, M. Rouse, M. Schlaifer, Shelley H. Schliesser, M. Shepherd, Jonalan Smith, A. Vaida, W. Wade, T. Woller, J. Woon","doi":"10.2146/AJHP080413","DOIUrl":null,"url":null,"abstract":"The multiplicity of drugs available and the complexities surrounding their safe and effective use make it necessary for organized health-care settings to have a sound program for maximizing rational drug use. The pharmacy and therapeutics (P&T) committee, or its equivalent, is the organizational keystone to this program. The P&T committee evaluates the clinical use of drugs, develops policies for managing drug use and drug administration, and manages the formulary system. This committee is composed of physicians, pharmacists, and other health professionals selected with the guidance of the medical staff. It is a policy-recommending body to the medical staff and the administration of the organization on matters related to the therapeutic use of drugs.","PeriodicalId":7452,"journal":{"name":"American journal of hospital pharmacy","volume":"23 1","pages":"2008-9"},"PeriodicalIF":0.0000,"publicationDate":"2008-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"26","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of hospital pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2146/AJHP080413","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 26

Abstract

The multiplicity of drugs available and the complexities surrounding their safe and effective use make it necessary for organized health-care settings to have a sound program for maximizing rational drug use. The pharmacy and therapeutics (P&T) committee, or its equivalent, is the organizational keystone to this program. The P&T committee evaluates the clinical use of drugs, develops policies for managing drug use and drug administration, and manages the formulary system. This committee is composed of physicians, pharmacists, and other health professionals selected with the guidance of the medical staff. It is a policy-recommending body to the medical staff and the administration of the organization on matters related to the therapeutic use of drugs.
美国儿科学会关于药学和治疗学委员会的声明。
由于现有药物的多样性及其安全有效使用的复杂性,有组织的卫生保健机构必须有一个健全的方案,以最大限度地合理使用药物。药学和治疗学(P&T)委员会,或其同等机构,是该计划的组织基石。P&T委员会评估药物的临床使用,制定管理药物使用和药物管理的政策,并管理处方系统。该委员会由在医务人员的指导下选出的医生、药剂师和其他卫生专业人员组成。它是向医务人员和本组织行政部门就与药物治疗使用有关的事项提出政策建议的机构。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信